Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

Shanghai Conant Optical / Equity Bottom-Up

<ul>
<li>In 1H25, <a href="https://www.smartkarma.com/entities/shanghai-conant-optical-co-ltd" target="_blank" data-smartkarma-citation="entities:33004:1" rel="noopener">Shanghai Conant Optical (2276 HK)</a> reported revenue rise of 11% to RMB 1.1M buoyed by growth across segments like multifunctional lens (up 9%) and standardized lens (up 20%).</li>
<li>In 1H25, the company kept up with its consistency of expanding its gross margins period after period, as margin expanded from 39.2% in 1H24 to 41% in 1H25 (2024: 38.6%).</li>
<li>Shanghai Conant’s robust demand outlook, capacity expansion plans, R&amp;D initiatives and margin strength offer a strong long term secular growth story.</li>
</ul>


In 1H25, Shanghai Conant Optical (2276 HK) reported revenue rise of 11% to RMB 1.1M buoyed by growth across segments like multifunctional lens (up 9%) and standardized lens (up 20%).
In 1H25, the company kept up with its consistency of expanding its gross margins period after period, as margin expanded from 39.2% in 1H24 to 41% in 1H25 (2024: 38.6%).
Shanghai Conant’s robust demand outlook, capacity expansion plans, R&amp;D initiatives and margin strength offer a strong long term secular growth story.


Conant Optical (2276 HKG): Growth Optics Sharp & Clear with Expanding Margins, Robust Sales in 1H25

HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Shanghai Conant Optical / Equity Capital Markets

<p>On April 1, 2021, <a href="https://www.smartkarma.com/entities/shanghai-conant-optical-co-ltd" target="_blank" data-smartkarma-citation="entities:33004:1" rel="noopener">Shanghai Conant Optical (SCO CH)</a> submitted its IPO prospectus to the Hong Kong Stock Exchange. Actually, <a href="https://www.smartkarma.com/entities/shanghai-conant-optics-co-a" target="_blank" data-smartkarma-citation="entities:8902:1" rel="noopener">Shanghai Conant Optics Co A (300061 CH)</a> became listed in the Shenzhen Stock Exchange in March 2010. At the time of listing, the Company enjoyed high reputation as the leading resin spectacle lens manufacturer in China and also had wide business exposure in the global market. However, after becoming a public company, the net profit attributed to shareholders of Conant Optical was RMB16 million in 2010 (down 25% YoY), RMB9.56 million in 2011 (down 40% YoY) and RMB(-840,000) in 2012 (down 109% YoY), decreasing for three consecutive years. So, how about Conant Optical after more than a decade? The following mainly analyzed the strength and concerns for the Company.</p>

On April 1, 2021, Shanghai Conant Optical (SCO CH) submitted its IPO prospectus to the Hong Kong Stock Exchange. Actually, Shanghai Conant Optics Co A (300061 CH) became listed in the Shenzhen Stock Exchange in March 2010. At the time of listing, the Company enjoyed high reputation as the leading resin spectacle lens manufacturer in China and also had wide business exposure in the global market. However, after becoming a public company, the net profit attributed to shareholders of Conant Optical was RMB16 million in 2010 (down 25% YoY), RMB9.56 million in 2011 (down 40% YoY) and RMB(-840,000) in 2012 (down 109% YoY), decreasing for three consecutive years. So, how about Conant Optical after more than a decade? The following mainly analyzed the strength and concerns for the Company.

Pre-IPO Shanghai Conant Optical - Here Are the Strength and the Concerns

China

Shanghai Conant Optics Co Ltd manufactures hard resin lens, glasses and accessories.  The Company's products include single vision lens, bifocal lens, progressive lens, middle to high index lens, polarized lens, and photochromic lens.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Shanghai Conant Optics Co A (300061 CH)

Conant Optical (2276 HKG): Growth Optics Sharp & Clear with Expanding Margins, Robust Sales in 1H25

Shanghai Conant Optical sees 11% revenue rise and consistent margin expansion in 1H25. Robust demand outlook, capacity expansion plans, and margin...

Tina Banerjee

Pre-IPO Shanghai Conant Optical - Here Are the Strength and the Concerns

This article analyzed both the strength and concerns for Shanghai Conant Optical, and whether it could get rid of the declining performance...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Conant Optical (2276 HKG): Growth Optics Sharp & Clear with Expanding Margins, Robust Sales in 1H25

​Shanghai Conant Optical sees 11% revenue rise and consistent margin expansion in 1H25. Robust demand outlook, capacity expansion plans, and margin...

Tina Banerjee

Pre-IPO Shanghai Conant Optical - Here Are the Strength and the Concerns

This article analyzed both the strength and concerns for Shanghai Conant Optical, and whether it could get rid of the declining performance...

Xinyao (Criss) Wang

Shanghai Conant Optical sees 11% revenue rise and consistent margin expansion in 1H25. Robust demand outlook, capacity expansion plans, and margin...